Rosen Law Firm Investigating Potential Securities Fraud Claims Against Apimeds Pharmaceuticals

Firm Encourages Investors to Inquire About Class Action Lawsuit

Apr. 15, 2026 at 10:36pm

Got story updates? Submit your updates here. ›

A minimalist, photorealistic studio still life featuring a stack of glass and metal pharmaceutical bottles and vials arranged on a clean white background, conceptually representing the abstract legal and financial issues facing the pharmaceutical company Apimeds.A carefully curated still life of pharmaceutical products hints at the legal and financial risks facing Apimeds Pharmaceuticals.NYC Today

The Rosen Law Firm, a global investor rights law firm, has announced an investigation into potential securities fraud claims on behalf of shareholders of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS). The firm believes Apimeds may have issued materially misleading information to the investing public.

Why it matters

The Rosen Law Firm is a prominent securities litigation firm that has achieved significant settlements for investors, including the largest-ever class action settlement against a Chinese company. This investigation signals potential issues with Apimeds' disclosures that could impact shareholder value.

The details

The Rosen Law Firm is preparing a class action lawsuit seeking to recover investor losses related to the alleged misleading information from Apimeds. Investors who purchased Apimeds securities may be eligible for compensation through a contingency fee arrangement with the firm.

  • The investigation was announced on April 15, 2026.

The players

Rosen Law Firm

A global investor rights law firm that specializes in securities class actions and shareholder derivative litigation. The firm has achieved significant settlements for investors, including the largest-ever class action settlement against a Chinese company.

Apimeds Pharmaceuticals US, Inc.

A pharmaceutical company listed on the NYSE American exchange under the ticker symbol APUS.

Got photos? Submit your photos here. ›

What they’re saying

“If you purchased Apimeds securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.”

— Phillip Kim, Attorney, Rosen Law Firm

What’s next

Investors interested in joining the potential class action lawsuit can contact the Rosen Law Firm through their website or by calling the firm's toll-free number.

The takeaway

This investigation by the prominent Rosen Law Firm suggests potential issues with Apimeds' disclosures that could impact shareholder value, highlighting the importance of due diligence and legal recourse for investors in such situations.